Trial Profile
An Open-label, Multi Centre Drug-drug Interaction Trial to Investigate the Effects of Tralokinumab on the Pharmacokinetics of Selected Cytochrome P450 Substrates in Adult Subjects With Moderate-to-severe Atopic Dermatitis
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Tralokinumab (Primary) ; Caffeine; Metoprolol; Midazolam; Omeprazole; Warfarin
- Indications Atopic dermatitis
- Focus Pharmacokinetics
- Acronyms ECZTRA 4
- Sponsors LEO Pharma
- 23 Oct 2020 Status changed from active, no longer recruiting to completed.
- 08 Oct 2020 Planned End Date changed from 28 Aug 2020 to 6 Sep 2021.
- 25 Nov 2019 Status changed from recruiting to active, no longer recruiting.